About
Basic Data Updated:
1 month agoBayer Pharmaceuticals Private Limited, a renowned company in the healthcare industry, is divided into three strategic business units: pharmaceutical healthcare, animal healthcare, and consumer care. These units work together to provide high-quality products and services to their customers. In November 2017, a credit rating report revealed that BPPL's pharmaceuticals portfolio consists of various formulations, with a major focus on the diabetics segment. Additionally, they offer a wide range of products in categories such as antibiotics, anti-infective, anti-hypertensive, female contraceptives, and appetite-stimulants. These products are carefully developed and tested to ensure the utmost effectiveness and safety for patients. The animal healthcare division of BPPL offers a diverse range of products for companion animals, poultry animals, and cattle. These include anti-flea treatments, anti-infective medications, soaps, and de-worming products. The company is dedicated to providing the best care for animals and ensuring their health and well-being. In the consumer care segment, BPPL markets a variety of skincare products. These products are designed to cater to the needs of different skin types and provide effective solutions for various skin concerns. The company is committed to promoting healthy and radiant skin for their customers.
Industry
Company Details
- Location
Thane, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U05195MH1998PTC116021 |
| Company No. | 116021 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 29 Jul 1998 |
| Date of AGM | 27 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Mumbai |
Products or Services related to Bayer Pharmaceuticals Private Limited
Diabetes Monitors
Test Strips & Lancets
Financials of Bayer Pharmaceuticals Private Limited
Bayer Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 166.44% increase. The company also saw a substantial fall in profitability, with a 48.66% decrease in profit. The company's net worth Soared by an impressive increase of 20.01%.
Corporate Structure
Unlock access to Bayer Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Bayer Pharmaceuticals Private Limited
Unlock and access historical data on people associated with Bayer Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(2)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Dec 2000 | ₹3.00 Cr | Satisfied |
Union Bank Of India Creation Date: 13 Nov 2000 | ₹4.00 Cr | Satisfied |
Union Bank Of India Creation Date: 13 Nov 2000 | ₹4.00 M | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bayer Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bayer Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Bayer Zydus Pharma Private Limited
Active
13 years 3 months Kunal Jha and Shweta Rai are mutual person
Recent activity within the organization
Director Appointment
Kunal Jha was appointed as a Additional Director was appointed as a Additional Director on 28 Mar 2024 & has been associated with this company since 2 months 6 days .
28 Mar 2024Director Appointment
Shweta Rai was appointed as a Additional Director was appointed as a Additional Director on 11 Jan 2024 & has been associated with this company since 4 months 22 days .
11 Jan 2024Annual General Meeting
Bayer Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2023 as per latest MCA records.
27 Sep 2023Balance Sheet
Bayer Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Charges
A charge registered on 13 Nov 2000 via Charge ID 90143114 with Union Bank Of India was fully satisfied on 26 Jul 2014.
26 Jul 2014
Recent News, Updates & Announcement
Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease.Sun Pharma has partnered up with Bayer to market Finerenone a drug for chronic kidney disease in India Bayer grants nonexclusive rights to Sun Pharma to distribute Finerenone under the brand name Lyvelsa Sun Pharma CEO emphasizes commitment to providing innovative medicines to Indian patients .
Economic Times 17 Jan 2024
- TCS Repeatable CarveOut Model helps Bayer Complete Multiple Divestitures On Time.
Business Standard 29 Oct 2018
- Reviewing order by Aus court on patent infringement Lupin.
Moneycontrol 05 Apr 2017
- How acquisitions work in Snapdeal.
YourStory 23 Oct 2016
Frequently asked questions
What is the Incorporation or founding date of Bayer Pharmaceuticals Private Limited?
